Thrombotic thrombocytopenic purpura: The masquerader

Southern Medical Journal

Volumn 102, Issue 5, 2009, Pages 504-509

  Patel, Anil ^a   Patel, Harsh ^a   Patel, Anush ^a  

^a NONE

Author keywords

Malignant hypertension; Microangiopathic hemolytic anemia; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; BILIRUBIN; CREATININE; DILTIAZEM; FUROSEMIDE; HEMOGLOBIN; LACTATE DEHYDROGENASE; METOPROLOL; NICARDIPINE; NITROPRUSSIDE SODIUM; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ANTIHYPERTENSIVE THERAPY; ARTERY; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BLOOD SMEAR; BLOOD VESSEL WALL; BODY TEMPERATURE; BRAIN DISEASE; CAPILLARY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; EMERGENCY CARE; ENDOTHELIUM INJURY; EXUDATE; FATIGUE; FEVER; HEADACHE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MALIGNANT HYPERTENSION; MICROCIRCULATION; MORTALITY; NEPHROSCLEROSIS; NEUROLOGIC DISEASE; OPHTHALMOLOGY; PAPILLEDEMA; PERIPHERAL EDEMA; PLASMAPHERESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA HEMORRHAGE; REVIEW; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR NECROSIS; WEAKNESS; BLOOD; CHRONIC KIDNEY FAILURE; ERYTHROCYTE DISORDER; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY;

ADAM PROTEINS; ADULT; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTES, ABNORMAL; HUMANS; HYPERTENSION, MALIGNANT; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MICROVESSELS; NEPHROSCLEROSIS; NICARDIPINE; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VASODILATOR AGENTS;

EID: 65649099658     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31819f330e     Document Type: Review

References (31)

1. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.
2. Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 1989;2:486-492. (Pubitemid 19168237)
3. Gardiner DS, Lindop GB. Peripolar cells, granulated glomerular epithelial cells, and their relationship to the juxtaglomerular apparatus in malignant hypertension. J Pathol 1992;167:59-64.
4. Möhring J, Möhring B, Näumann H-J, et al. Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol 1975;228:1847-1855.
5. McAllister RG Jr, Van Way CW III, Dayani K, et al. Malignant hypertension: effect of therapy on renin and aldosterone. Circ Res 1971;28(suppl 2):160-174.
6. Montgomery HE, Kiernan LA, Whitworth CE, et al. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens 1998;16:635-643.
7. Brain MC. Microangiopathic hemolytic anemia. N Engl J Med 1969;281:833-835.
8. Sanerkin NG. Vascular lesions of malignant essential hypertension. J Pathol 1971;103:177-184.
9. Jones DB. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest 1974;31:303-313.
10. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000;356:411-417.
11. Kadiri S, Olutade BO. The clinical presentation of malignant hypertension in Nigerians. J Hum Hypertens 1991;5:339-343.
12. Cohen JA, Brecher ME, Bandarenko N. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apher 1998;13:16-19. (Pubitemid 28215135)
13. Amorosi EL, Ultmann JE. Thrombocytopic purpura: report of 16 cases and review of the literature. Medicine (Baltimore) 1966;45:139-159.
14. Moake JL, Turner NA, Stathopoulos NA, et al. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986;78:1456-1461.
15. Arya M, Anvari B, Romo GM, et al. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 2002;99:3971-3977. (Pubitemid 35332036)
16. Sadler JE, Moake JL, Miyata T, et al. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004:407-423.
17. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002;100:4033-4039. (Pubitemid 35396870)
18. Dong JF, Moake JL, Bernardo A, et al. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor. J Biol Chem 2003;278:29633-29639. (Pubitemid 36962347)
19. Moake JL. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol 2004;41:4-14. (Pubitemid 38057780)
20. Zheng X, Majerus EM, Sadler JE. ADAMTS13 and TTP. Curr Opin Hematol 2002;9:389-394.
21. Ruggeri ZM. Developing basic and clinical research on von Willebrand factor and von Willebrand disease. Thromb Haemost 2000;84:147-149. (Pubitemid 30601456)
22. Peyvandi F, Lavoretano S, Palla R, et al. Mechanisms of the interaction between two ADAMTS13 gene mutations leading to severe deficiency of enzymatic activity. Hum Mutat 2006;27:330-336.
23. Schneppenheim R, Budde U, Oyen F, et al. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood 2003;101:1845-1850. (Pubitemid 36237583)
24. Peyvandi F, Lavoretano S, Palla R, et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 2008;93:232-239.
25. Ono T, Mimuro J, Madoiwa S, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 2006;107:528-534. (Pubitemid 43076375)
26. van den Born BJ, van der Hoeven NV, Groot E, et al. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension 2008;51:862-866. (Pubitemid 351654696)
27. George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000;96:1223-1229.
28. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006;354:1927-1935.
29. Allford SL, Hunt BJ, Rose P, et al. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003;120:556-573.
30. Darabi K, Berg AH. Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP. Am J Clin Pathol 2006;125:592-597.
31. Jasti S, Coyle T, Gentile T, et al. Rituximab as an adjunct to plasma exchange in TTP: a report of 12 cases and review of literature. J Clin Apher 2008;23:151-156.